|
This Masterclass is designed for healthcare professionals [4 CME points accredited]
Jubilee Ballroom, Level 4.
Event description
The immune system weakens with age and this concept is named “immunosenescence”. Immunosenescence contributes to a reduced ability to respond to natural infections but also to develop optimal immunity following
administration of some vaccines. Indeed, while vaccines against tetanus, diphtheria, pertussis and hepatitis have demonstrated immunogenicity andacceptable safety profiles in older adults, some other vaccines have only limited efficacy.
As the population of countries age, an increasing proportion of adults are therefore at increased risk of infectious diseases including those that are preventable by vaccination. Although a number of vaccines are currently recommended for older adults, vaccination coverage in this particular group remains low.
Fortunately, novel technology has facilitated the development of new and/or improved vaccines for adults that could significantly contribute to the implementation of healthy aging strategies. A large panel of renowned immunologists, microbiologists, vaccinologists, public health experts, infectious diseases specialists, and geriatricians will share their clinical experience with vaccine-preventable disease in older patients and
explain the mechanisms of immunosenescence and the impact of immune aging on vaccination, but also provide the latest developments in vaccine science that may improve the efficacy of vaccines in this age group.
|
